Literature DB >> 11782613

Collagenous colitis associated with lansoprazole.

Gilbert M Wilcox1, Anthony Mattia.   

Abstract

BACKGROUND: Collagenous colitis is a diarrheal illness of unknown cause. The purpose of this report is to describe a case of collagenous colitis related to lansoprazole exposure. STUDY: Case report.
RESULTS: A patient is described who developed clinical and pathologic findings of collagenous colitis during treatment with lansoprazole and omeprazole. Symptoms of diarrhea and histopathologic abnormalities resolved after drug withdrawal and recurred with re-exposure to lansoprazole.
CONCLUSIONS: The observations are compatible with collagenous colitis or lymphocytic colitis associated with exposure to lansoprazole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782613     DOI: 10.1097/00004836-200202000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

1.  Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.

Authors:  Amy J Thorsen
Journal:  Clin Colon Rectal Surg       Date:  2007-02

2.  Collagenous colitis appeared after 6-year administration of lansoprazole.

Authors:  Koji Sawada; Mikihiro Fujiya; Kentaro Itabashi; Yasuyuki Suzuki; Koji Kubo; Toshie Nata; Nobuhiro Ueno; Yuhei Inaba; Kentaro Moriichi; Kotaro Okamoto; Katsuya Ikuta; Hiroki Tanabe; Yusuke Mizukami; Yoshitake Takagi; Yutaka Kohgo
Journal:  Clin J Gastroenterol       Date:  2009-11-28

Review 3.  Long-term natural history and complications of collagenous colitis.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

4.  An epidemiological study of collagenous colitis in southern Sweden from 2001-2010.

Authors:  Lina Vigren; Martin Olesen; Cecilia Benoni; Klas Sjöberg
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

5.  Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide.

Authors:  P Verschueren; A K Vandooren; R Westhovens
Journal:  Clin Rheumatol       Date:  2004-11-23       Impact factor: 2.980

6.  Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.

Authors:  Cristina Pozzoli; Alessandro Menozzi; Daniela Grandi; Elvira Solenghi; Maria C Ossiprandi; Chiara Zullian; Simone Bertini; Giulia M Cavestro; Gabriella Coruzzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-07       Impact factor: 3.000

7.  The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.

Authors:  Eugen Melcescu; Reed B Hogan; Keith Brown; Stewart A Boyd; Thomas L Abell; Christian A Koch
Journal:  Exp Mol Pathol       Date:  2012-10-05       Impact factor: 3.362

8.  Lymphocytic colitis associated with lansoprazole treatment.

Authors:  Zahide Simsek; Hakan Alagozlu; Candan Tuncer; Ayse Dursun
Journal:  Curr Ther Res Clin Exp       Date:  2007-09

9.  Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis.

Authors:  Mitsuro Chiba; Takeshi Sugawara; Haruhiko Tozawa; Hidehiko Tsuda; Toru Abe; Takuo Tokairin; Iwao Ono; Eriko Ushiyama
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

Review 10.  Microscopic colitis.

Authors:  Gianluca Ianiro; Giovanni Cammarota; Luca Valerio; Brigida Eleonora Annicchiarico; Alessandro Milani; Massimo Siciliano; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.